| Height, cm | |
| Concomitant Diseases | No |
| Lab Tests | CBC: 17-Apr-2024: RBC: 4.2*1012/L; HGB: 126 g/L; PLT: 273*109/L; WBC: 6.8*109/L; NEU: 67%; EOS: 1%; BAS: 0%; LYM: 31%; MON: 1%; ESR 36 mm/hour. Biochemistry: 17-Apr-2024: Total protein: 72 g/L; Total bilirubin: 11.9 μmol/L; ALAT: 12 u/L; ASAT: 11 u/L; Creatinine: 83 μmol/L; Urea: 6.1 mmol/L; Glucose: 4.8 mmol/L |
| N (Node) | pN0 |
| Treatment of Concomitant Diseases | No |
| M (Metastasis) | cM1 |
| Date of diagnosis | 2024/4/11 |
| Drinking History | Occasional drinker |
| Biomarkers | 26-Apr-2024: ER negative; PR negative; HER2 negative; Ki-67 20% |
| Race | Caucasian |
| Stage of disease | IV |
| Treatment | Not treated |
| Date of Draw | 2024/5/17 |
| Processing | Single spin |
| Weight, kg | 87 |
| Pathology Report | Invasive carcinoma of no special type (NST) of the left breast, tumor size: 6.3 cm in diameter. Mts: right lung. |
| Grade | G3 |
| COVID-19 Vaccination | Unvaccinated |
| Clinical diagnosis | TNBC: Invasive carcinoma of no special type (NST) |
| T (Tumor) | pT4 |
| HIV, HBV, HCV, RPR | Negative |
| Location Country | Ukraine |
| Smoking History | Non-smoker |
| Cancer History and Relapses | No |
